Biotech Startup Raises $5 Million

Impedance Cardiology Systems Inc., a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Menlo Park, Calif.-based biotech startup, has raised $5 million in Series B funding, according to a regulatory filing. Backers include Versant Ventures and Starfish Ventures (Australia). < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />